Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy caused a woman's permanent hair loss and early menopause.

Non-myeloablative stem cell transplants are a promising, less toxic option for older or weaker patients, with fewer side effects and good outcomes.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

New treatments for epidermolysis bullosa show promise in improving patients' lives, but a cure is still not available.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

Changing the environment around stem cells could help tissue repair, but it's hard to be precise and avoid side effects.

Stem cell therapies may help improve symptoms and quality of life for people with epidermolysis bullosa.

Artificial skin grafts face immune rejection, but stem cells may improve future designs.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Biomaterials combined with stem cells show promise for improving tissue repair and medical treatments.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

The meeting highlighted important advances in stem cell research and its potential for creating new medical treatments.

Islamic perspectives in Malaysia raise ethical concerns about using stem cells, especially from embryos, for beauty and medical treatments.

Chemicals and stem cells combined have advanced regenerative medicine with few safety concerns, focusing on improving techniques and treatment effectiveness.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Umbilical cord blood is a valuable source of stem cells for medical treatments, but its use is less common than other transplants, and there are ethical issues to consider.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Stem cell therapy shows promise for treating skin disorders.

Entospletinib effectively prevents eye and skin GVHD in mice.

Stem cells have great potential for treating various medical conditions.

Older age and prostatic hyperplasia in males increase the risk of hemorrhagic cystitis after stem cell transplantation.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.